In the training set of patients, the metastasis rate in the patients with a high frequency (>19.5%) of CD44-/CD24- breast cancer cells was 1.97-fold higher than those with a low frequency (<19.5%) of CD44-/CD24- tumor cells. Here, CD44 is linked to neoplasm.